Cargando…

A microfluidic strategy to capture antigen-specific high affinity B cells

Assessing B cell affinity to pathogen-specific antigens prior to or following exposure could facilitate the assessment of immune status. Current standard tools to assess antigen-specific B cell responses focus on equilibrium binding of the secreted antibody in serum. These methods are costly, time-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhassan, Ahmed M., Shirure, Venktesh S., Luo, Jean, Nguyen, Bryan B., Rollins, Zachary A., Shergill, Bhupinder S., Zhu, Xiangdong, Baumgarth, Nicole, George, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369944/
https://www.ncbi.nlm.nih.gov/pubmed/37503139
http://dx.doi.org/10.1101/2023.07.12.548739
_version_ 1785077865268641792
author Alhassan, Ahmed M.
Shirure, Venktesh S.
Luo, Jean
Nguyen, Bryan B.
Rollins, Zachary A.
Shergill, Bhupinder S.
Zhu, Xiangdong
Baumgarth, Nicole
George, Steven C.
author_facet Alhassan, Ahmed M.
Shirure, Venktesh S.
Luo, Jean
Nguyen, Bryan B.
Rollins, Zachary A.
Shergill, Bhupinder S.
Zhu, Xiangdong
Baumgarth, Nicole
George, Steven C.
author_sort Alhassan, Ahmed M.
collection PubMed
description Assessing B cell affinity to pathogen-specific antigens prior to or following exposure could facilitate the assessment of immune status. Current standard tools to assess antigen-specific B cell responses focus on equilibrium binding of the secreted antibody in serum. These methods are costly, time-consuming, and assess antibody affinity under zero-force. Recent findings indicate that force may influence BCR-antigen binding interactions and thus immune status. Here, we designed a simple laminar flow microfluidic chamber in which the antigen (hemagglutinin of influenza A) is bound to the chamber surface to assess antigen-specific BCR binding affinity of five hemagglutinin-specific hybridomas under 65- to 650-pN force range. Our results demonstrate that both increasing shear force and bound lifetime can be used to enrich antigen-specific high affinity B cells. The affinity of the membrane-bound BCR in the flow chamber correlates well with the affinity of the matched antibodies measured in solution. These findings demonstrate that a microfluidic strategy can rapidly assess BCR-antigen binding properties and identify antigen-specific high affinity B cells. This strategy has the potential to both assess functional immune status from peripheral B cells and be a cost-effective way of identifying individual B cells as antibody sources for a range of clinical applications.
format Online
Article
Text
id pubmed-10369944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-103699442023-07-27 A microfluidic strategy to capture antigen-specific high affinity B cells Alhassan, Ahmed M. Shirure, Venktesh S. Luo, Jean Nguyen, Bryan B. Rollins, Zachary A. Shergill, Bhupinder S. Zhu, Xiangdong Baumgarth, Nicole George, Steven C. bioRxiv Article Assessing B cell affinity to pathogen-specific antigens prior to or following exposure could facilitate the assessment of immune status. Current standard tools to assess antigen-specific B cell responses focus on equilibrium binding of the secreted antibody in serum. These methods are costly, time-consuming, and assess antibody affinity under zero-force. Recent findings indicate that force may influence BCR-antigen binding interactions and thus immune status. Here, we designed a simple laminar flow microfluidic chamber in which the antigen (hemagglutinin of influenza A) is bound to the chamber surface to assess antigen-specific BCR binding affinity of five hemagglutinin-specific hybridomas under 65- to 650-pN force range. Our results demonstrate that both increasing shear force and bound lifetime can be used to enrich antigen-specific high affinity B cells. The affinity of the membrane-bound BCR in the flow chamber correlates well with the affinity of the matched antibodies measured in solution. These findings demonstrate that a microfluidic strategy can rapidly assess BCR-antigen binding properties and identify antigen-specific high affinity B cells. This strategy has the potential to both assess functional immune status from peripheral B cells and be a cost-effective way of identifying individual B cells as antibody sources for a range of clinical applications. Cold Spring Harbor Laboratory 2023-07-14 /pmc/articles/PMC10369944/ /pubmed/37503139 http://dx.doi.org/10.1101/2023.07.12.548739 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Alhassan, Ahmed M.
Shirure, Venktesh S.
Luo, Jean
Nguyen, Bryan B.
Rollins, Zachary A.
Shergill, Bhupinder S.
Zhu, Xiangdong
Baumgarth, Nicole
George, Steven C.
A microfluidic strategy to capture antigen-specific high affinity B cells
title A microfluidic strategy to capture antigen-specific high affinity B cells
title_full A microfluidic strategy to capture antigen-specific high affinity B cells
title_fullStr A microfluidic strategy to capture antigen-specific high affinity B cells
title_full_unstemmed A microfluidic strategy to capture antigen-specific high affinity B cells
title_short A microfluidic strategy to capture antigen-specific high affinity B cells
title_sort microfluidic strategy to capture antigen-specific high affinity b cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369944/
https://www.ncbi.nlm.nih.gov/pubmed/37503139
http://dx.doi.org/10.1101/2023.07.12.548739
work_keys_str_mv AT alhassanahmedm amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT shirurevenkteshs amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT luojean amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT nguyenbryanb amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT rollinszacharya amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT shergillbhupinders amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT zhuxiangdong amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT baumgarthnicole amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT georgestevenc amicrofluidicstrategytocaptureantigenspecifichighaffinitybcells
AT alhassanahmedm microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT shirurevenkteshs microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT luojean microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT nguyenbryanb microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT rollinszacharya microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT shergillbhupinders microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT zhuxiangdong microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT baumgarthnicole microfluidicstrategytocaptureantigenspecifichighaffinitybcells
AT georgestevenc microfluidicstrategytocaptureantigenspecifichighaffinitybcells